Treatment of impetigo and antimicrobial resistance
A recent review in Journal of Drugs in Dermatology reviewed the information provided to physicians and stakeholders regarding antimicrobial resistance (AMR) in the treatment of impetigo.
Impetigo is a contagious bacterial infection that affects the superficial layers of the skin, and topical agents prescribed for the condition are seeing an increase in AMR worldwide, causing treatment to fail. In response, the World Health Organization (WHO) developed a comprehensive action plan on AMR but omitted information on the AMR management program for topical antibiotics.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!